Kusatsu, Japan

Shinya Mori

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ishihara Sangyo Kaisha, Ltd.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinya Mori. Retrieved from https://idiyas.com/inventor/shinya-mori-mswozm8z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile




Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shinya Mori: Innovator in Cytokine Production Inhibitors

Introduction

Shinya Mori is a notable inventor based in Kusatsu, Japan. He has made significant contributions to the field of medicine, particularly in the development of cytokine production inhibitors. His work aims to provide therapeutic solutions for diseases characterized by hyperactivated immune functions.

Latest Patents

Mori holds a patent for "Thioamides and salts thereof and cytokine production inhibitors containing both." This invention focuses on providing cytokine production inhibitors that can be utilized as preventive or therapeutic medicines. The active ingredient in this patent is a thioamide compound, which is represented by a specific chemical formula. This compound is designed to inhibit cytokine production, thereby addressing various medical conditions.

Career Highlights

Shinya Mori is associated with Ishihara Sangyo Kaisha, Ltd., where he continues to innovate and contribute to the field of pharmaceuticals. His dedication to research and development has led to advancements that could potentially improve patient outcomes in immune-related diseases.

Collaborations

Mori has collaborated with notable colleagues, including Fuminori Kato and Hirohiko Kimura. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Shinya Mori's work in cytokine production inhibitors exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for new therapeutic options that could benefit many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…